DK453089D0 - Farmaceutisk middel med afslappende virkning indeholdende en nitratester som aktiv forbindelse - Google Patents

Farmaceutisk middel med afslappende virkning indeholdende en nitratester som aktiv forbindelse

Info

Publication number
DK453089D0
DK453089D0 DK453089A DK453089A DK453089D0 DK 453089 D0 DK453089 D0 DK 453089D0 DK 453089 A DK453089 A DK 453089A DK 453089 A DK453089 A DK 453089A DK 453089 D0 DK453089 D0 DK 453089D0
Authority
DK
Denmark
Prior art keywords
tester
nitrate
active compound
pharmaceutical agent
relaxing effect
Prior art date
Application number
DK453089A
Other languages
English (en)
Other versions
DK453089A (da
Inventor
Jan Bron
Geert Jan Sterk
Jan Fetze Van Der Werf
Hendrik Timmerman
Original Assignee
Cedona Pharm Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cedona Pharm Bv filed Critical Cedona Pharm Bv
Publication of DK453089D0 publication Critical patent/DK453089D0/da
Publication of DK453089A publication Critical patent/DK453089A/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D493/00Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/21Esters, e.g. nitroglycerine, selenocyanates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/08Vasodilators for multiple indications
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C203/00Esters of nitric or nitrous acid
    • C07C203/02Esters of nitric acid
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C203/00Esters of nitric or nitrous acid
    • C07C203/02Esters of nitric acid
    • C07C203/04Esters of nitric acid having nitrate groups bound to acyclic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C203/00Esters of nitric or nitrous acid
    • C07C203/02Esters of nitric acid
    • C07C203/08Esters of nitric acid having nitrate groups bound to carbon atoms of rings other than six-membered aromatic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C205/00Compounds containing nitro groups bound to a carbon skeleton
    • C07C205/39Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by esterified hydroxy groups
    • C07C205/42Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by esterified hydroxy groups having nitro groups or esterified hydroxy groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D335/00Heterocyclic compounds containing six-membered rings having one sulfur atom as the only ring hetero atom
    • C07D335/04Heterocyclic compounds containing six-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D335/10Dibenzothiopyrans; Hydrogenated dibenzothiopyrans
    • C07D335/12Thioxanthenes
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00Systems containing only non-condensed rings
    • C07C2601/02Systems containing only non-condensed rings with a three-membered ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00Systems containing only non-condensed rings
    • C07C2601/12Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/14The ring being saturated
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2602/00Systems containing two condensed rings
    • C07C2602/02Systems containing two condensed rings the rings having only two atoms in common
    • C07C2602/14All rings being cycloaliphatic
    • C07C2602/26All rings being cycloaliphatic the ring system containing ten carbon atoms
    • C07C2602/28Hydrogenated naphthalenes
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2603/00Systems containing at least three condensed rings
    • C07C2603/02Ortho- or ortho- and peri-condensed systems
    • C07C2603/04Ortho- or ortho- and peri-condensed systems containing three rings
    • C07C2603/30Ortho- or ortho- and peri-condensed systems containing three rings containing seven-membered rings
    • C07C2603/32Dibenzocycloheptenes; Hydrogenated dibenzocycloheptenes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Emergency Medicine (AREA)
  • Epidemiology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Quinoline Compounds (AREA)
  • Furan Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Indole Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
DK453089A 1988-09-15 1989-09-14 Farmaceutisk middel med afslappende virkning indeholdende en nitratester som aktiv forbindelse DK453089A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
NL8802276A NL8802276A (nl) 1988-09-15 1988-09-15 Geneesmiddel met relaxerende werking, dat als aktieve stof een nitraatester bevat.

Publications (2)

Publication Number Publication Date
DK453089D0 true DK453089D0 (da) 1989-09-14
DK453089A DK453089A (da) 1990-03-16

Family

ID=19852906

Family Applications (1)

Application Number Title Priority Date Filing Date
DK453089A DK453089A (da) 1988-09-15 1989-09-14 Farmaceutisk middel med afslappende virkning indeholdende en nitratester som aktiv forbindelse

Country Status (13)

Country Link
US (1) US5049694A (da)
EP (1) EP0359335A3 (da)
JP (1) JPH02134316A (da)
KR (1) KR900004331A (da)
AU (1) AU638413B2 (da)
DK (1) DK453089A (da)
FI (1) FI894349A (da)
IL (1) IL91602A0 (da)
NL (1) NL8802276A (da)
NO (1) NO171904C (da)
NZ (1) NZ230631A (da)
PT (1) PT91701B (da)
ZA (1) ZA896982B (da)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1243367B (it) * 1990-07-26 1994-06-10 Italfarmaco Spa Derivati acidi benzoici sostituiti ad attivita' cardiovascolare
NL9001955A (nl) * 1990-09-05 1992-04-01 Cedona Pharm Bv Nieuwe thiazolidinederivaten.
JP3454531B2 (ja) * 1991-11-07 2003-10-06 三共株式会社 ニトロキシアルキルアミド誘導体
US5646181A (en) * 1992-07-02 1997-07-08 Research Foundation Of State University Of New York Method and compositions for treating impotence
IT1256450B (it) * 1992-11-26 1995-12-05 Soldato Piero Del Esteri nitrici con attivita' farmacologica e procedimento per la loro preparazione
WO1994021248A1 (de) * 1993-03-15 1994-09-29 Byk Nederland Bv Verwendung von substituierten alkylnitraten zur behandlung des krankhaft erhöhten augeninnendruckes
ES2065291B1 (es) * 1993-07-30 1995-10-01 Prodesfarma Sa "nitrato esteres de 1-ariloxi-3-alquilamino-2-propanoles, utilizacion y composicion farmaceutica correspondiente"
WO1995009831A1 (en) * 1993-10-06 1995-04-13 Nicox S.A. Nitric esters having anti-inflammatory and/or analgesic activity and process for their preparation
WO1995019952A1 (de) * 1994-01-19 1995-07-27 Byk Nederland Bv Nitroxy-gruppen enthaltende benzylaminderivate und ihre verwendung zur behandlung von cardiovasculären erkrankungen sowie erhöhtem augeninnendruck
US5925658A (en) * 1995-03-02 1999-07-20 Sankyo Company, Limited Optically active thiazolidinone derivative
US6310052B1 (en) 1996-06-04 2001-10-30 Queen's University At Kingston Nitrate esters and their use for neurological conditions
US7115661B1 (en) 1999-12-29 2006-10-03 Queen's University At Kingston Methods and compositions for mitigating pain
US5807847A (en) * 1996-06-04 1998-09-15 Queen's University At Kingston Nitrate esters
US20050137191A1 (en) * 1996-06-04 2005-06-23 Thatcher Gregory R. Nitrate esters and their use for mitigating cellular damage
IL120531A (en) * 1997-03-26 2006-12-31 Yissum Res Dev Co Nitric oxide donors and pharmaceutical compositions containing them
US6056966A (en) * 1998-05-18 2000-05-02 Baker Norton Pharmaceuticals, Inc. Method and compositions for treating impotence
AU2003265769A1 (en) * 2002-05-02 2003-11-17 Ciphergen Biosystems, Inc. Biochips with surfaces coated with polysaccharide based hydrogels
JP4891982B2 (ja) * 2008-12-15 2012-03-07 スガツネ工業株式会社 2軸ヒンジ装置及び携帯機器
CN103739499B (zh) * 2011-10-24 2016-09-07 尼科斯科学爱尔兰公司 醌基一氧化氮供体化合物

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2139364A (en) * 1937-03-22 1938-12-06 Shell Dev Alpha-substituted glycerol nitrates
NL49919C (da) * 1938-02-10
US2294849A (en) * 1938-08-20 1942-09-01 Sharples Chemicals Inc Manufacture of nitric acid esters
US2549687A (en) * 1947-11-21 1951-04-17 Duriron Co Heat exchanger
GB713329A (en) * 1951-01-08 1954-08-11 Nat Res Dev Improvements in or relating to production of nitric acid esters of higher alcohols and glycols
US2683164A (en) * 1951-12-21 1954-07-06 Trojan Powder Co Preparation of 1, 2, 6-hexanetriol trinitrate
US2742492A (en) * 1954-07-29 1956-04-17 Ethyl Corp Nitrate formulations
NL98269C (da) * 1956-02-24
NL110701C (da) * 1960-03-14
US3428667A (en) * 1962-09-20 1969-02-18 Aerojet General Co N,n-dinitramines of certain organic compounds and process
US3419571A (en) * 1966-04-06 1968-12-31 Warner Lambert Pharmaceutical Method for relieving coronary insufficiency
US3409620A (en) * 1967-02-06 1968-11-05 Mario Biazzi Sa Dr Ing Continuous manufacture in vacuum of nitric esters and/or organic nitro compounds
US3470231A (en) * 1967-05-29 1969-09-30 Us Navy Method of stabilizing nitric acid esters
US3853891A (en) * 1971-06-16 1974-12-10 Sandoz Ag N-(n-(cyanoalkyl)-n-nitroso)amino-aminoalcohol
US4336408A (en) * 1977-11-25 1982-06-22 Thiokol Corporation 2-Hydroxymethyl-1,3-propanediol preparation
JPS56113748A (en) * 1980-02-13 1981-09-07 Kowa Co Aminoethanol derivative and its preparation
US4417903A (en) * 1982-10-15 1983-11-29 Ethyl Corporation Diesel fuel composition
DE3305690A1 (de) * 1983-02-18 1984-08-30 Heinrich Mack Nachf., 7918 Illertissen Glycerinmononitrate zur behandlung der angina pectoris
US4479905A (en) * 1983-09-19 1984-10-30 Ethyl Corporation Nitration process
DE3443998A1 (de) * 1984-12-01 1986-06-05 Boehringer Mannheim Gmbh, 6800 Mannheim Amino-propanol-derivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel sowie zwischenprodukte
DE3512627A1 (de) * 1985-04-06 1986-10-09 Boehringer Mannheim Gmbh, 6800 Mannheim Amino-propanol-derivate, verfahren zu deren herstellung, verwendung derselben und diese enthaltende arzneimittel

Also Published As

Publication number Publication date
NO171904C (no) 1993-05-19
ZA896982B (en) 1990-06-27
DK453089A (da) 1990-03-16
NO893686D0 (no) 1989-09-14
AU4133089A (en) 1990-03-22
EP0359335A3 (en) 1991-03-06
FI894349A0 (fi) 1989-09-14
NO893686L (no) 1990-03-16
PT91701A (pt) 1990-03-30
IL91602A0 (en) 1990-04-29
NL8802276A (nl) 1990-04-02
NO171904B (no) 1993-02-08
NZ230631A (en) 1993-01-27
KR900004331A (ko) 1990-04-12
AU638413B2 (en) 1993-07-01
PT91701B (pt) 1995-06-30
EP0359335A2 (en) 1990-03-21
JPH02134316A (ja) 1990-05-23
US5049694A (en) 1991-09-17
FI894349A (fi) 1990-03-16

Similar Documents

Publication Publication Date Title
DK453089A (da) Farmaceutisk middel med afslappende virkning indeholdende en nitratester som aktiv forbindelse
FI921606A (fi) Mikroperoxidas innehaollande hemopeptid som aktiv komponent.
NO308107B1 (no) Ikke-solvatert krystallinsk forbindelse, farmasøytisk formulering inneholdende denne samt anvendelse av forbindelsen for fremstilling av et farmasøytisk middel
NO891663L (no) Sjampo med lav ph som inneholder climbazol.
DK50191D0 (da) Orale farmaceutiske praeparater med colonselektiv afgivelse
LV10573A (lv) Panemiens farmaceitiska sastava iegusanai
NO180584C (no) Bisnaftalimider som inneholder aminosyreavledete linkere, for anvendelse som antikreftmidler, samt farmasöytiske preparater
DE69007592T2 (de) Transdermal absorbierbare Dopaminderivate enthaltende Arzneizubereitungen.
PT100928A (pt) Derivados de ciclopentano e ciclopenteno, composicoes farmaceuticas contendo estes compostos e seu uso
AT399878B (de) Kristallines cephalosporinsalz und dieses enthaltendes pharmazeutisches mittel
DK246984D0 (da) Dihydrobenzopyrrolobenzodiazepiner en fremgangsmaade til deres fremstilling samt deres anvendelse som laegemidler
FI890853A (fi) Farmaceutiskt preparat som tryggar transdermal absorption av den aktiva bestaondsdelen och foerfarande foer framstaellning daerav.
FI896091A0 (fi) Korkeatoimiset polarisaattorit
DK303688A (da) Polyoxygenerede labdanderivater, fremgangsmaade til deres fremstilling samt deres anvendelse som laegemidler
DK674589A (da) Benzenderivater og fremgangsmaade til fresmtilling deraf samt farmaceutiske midler indeholdende derivaterne
DK234489D0 (da) Farmaceutisk praeparat indeholdende et immunosuppressivt middel
DK681887A (da) Azolderivat, fremgangsmaade til fresmtilling heraf samt landburgsmaessigt/havebrugsmaessigt fungicid indeholdende derivatet som aktiv bestanddel
DK393788D0 (da) Substituerede thienoimidazolderivater, fremgangsmaader til deres fremstilling samt deres anvendelse som laegemidler
DK401988A (da) 11-substituerede 5-aryl-5h,11h-pyrrolo(2,1-c)-(1,4)benzoxazepiner, fremgangsmaade til deres fremstilling samt deres anvendelse som laegemidler
DK256689D0 (da) 1,2-dithiol-3-thion-s-oxid-forbindelser til anven delse som laegemidler
IT8521214A0 (it) Composizione farmaceutica solida per uso orale.
DK102988D0 (da) Middel med antidepressiv virkning
DK225189D0 (da) Hydrazinocarbonyloxylabdaner, fremgangsmaade til deres fremstilling samt deres anvendelse som laegemidler
DK444389A (da) Makrocycliske forbindelser, fremgangsmaade til deres fremstilling samt deres anvendelse som mikrobicider
DK162631C (da) Forbindelse, betegnet fr-900216, til anvendelse som terapeutisk aktivt stof, farmaceutisk praeparat indeholdende forbindelsen samt anvendelse af forbindelsen

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment